Suchergebnisse - "Pivot, Xavier"

PubPharm (424)

1

Short-term efficacy and safety of neoadjuvant pyrotinib plus taxanes for early HER2-positive breast cancer : a single-arm exploratory phase II trial

enthalten in: Gland surgery | 2024

von Ye, G. | Chen, P. | Liu, X. | +11

2

Subcutaneous Administration of a Zwitterionic Chitosan-Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies

enthalten in: Advanced materials (Deerfield Beach, Fla.) | 2024

von Gréa, T. | Jacquot, G. | Durand, A. | +27

3

Supramolecular Heterodimer Peptides Assembly for Nanoparticles Functionalization

enthalten in: Advanced healthcare materials | 2024

von Mathieu, C. | Ghosh, S. | Draussin, J. | +13

4

A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients

enthalten in: Journal of cachexia, sarcopenia and muscle | 2024

von Mallard, J. | Hucteau, E. | Bender, L. | +14

5

Subcutaneous Administration of a Zwitterionic Chitosan‐Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies

enthalten in: Advanced Materials | 2024

von Gréa, T. | Jacquot, G. | Durand, A. | +27

6

Influence of pneumatic transportation on the stability of monoclonal antibodies

enthalten in: Scientific reports | 2023

von Coliat, P. | Erb, S. | Diemer, H. | +8

7

Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast Cancer

enthalten in: Clinical breast cancer | 2023

von Pivot, X. | Spano, J. | Espie, M. | +15

8

PHARMACEUTICAL FORMULATION FOR SUBCUTANEOUS ADMINISTRATION OF PROTEINS

enthalten in: Europäisches Patentamt | 2023

von DETAPPE ALEXANDRE | PIVOT XAVIER | COLIAT PIERRE | +4

9

Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy

enthalten in: European journal of applied physiology | 2023

von Hucteau, E. | Mallard, J. | Pivot, X. | +6

10

Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer : Secondary Analysis of a Randomized Clinical Trial

enthalten in: JAMA network open | 2023

von Pivot, X. | Cortés, J. | Lüftner, D. | +17

CommentIn: JAMA Netw Open. 2023 Apr 3;6(4):e235776. - PMID 37022693

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[43]